ecrin-mdr-crcClinical2015Neoplasm MetastasisMelanomaSolid TumorsNeoplasm MetastasisMelanomaSolid TumorsInterventionalhttps://newmdr.ecrin.org/Study/2179977United StatesAustralia1Metastatic Solid TumorsMaximum Tolerated DoseRelapsed or refractory, BRAFV600 or RAS-mutated solid tumorsThyroid carcinomasLocally Advanced TumorsNon -small cell lung cancer [NSCLC]Pancreatic ductal AdenocarcinomasColorectal Carcinomas PapillaryECRIN MDRTerminatedfalseSafety and PK Study of CC-90003 in Relapsed/Refractory Solid TumorsThe CC-90003-ST -001 trial is a first-in-man, open-label study in subjects with locally-advanced or wide spread cancers to determine if CC-90003 (an oral medication) can be adequately tolerated with minimal side effects.2015-01-152179977NCT02313012